In short
Cedazuridine is an investigational drug currently being studied in clinical trials for the treatment of various blood cancers and solid tumors. It is often used in combination with other drugs, particularly decitabine, to potentially improve outcomes for patients with conditions such as myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and metastatic prostate cancer. This article summarizes the key findings from recent clinical trials exploring the use of cedazuridine in different cancer treatments.
At a glance
- Primary Uses
- Treatment of blood cancers (MDS, AML, CMML) and solid tumors
- Combination Therapies
- Often combined with decitabine; also studied with enzalutamide, venetoclax, and magrolimab
- Administration
- Oral tablets, typically given daily for 3-5 days in 28-day cycles
- Key Trials
- NCT04256317, NCT05960773, NCT04985656, NCT05037500
- Primary Outcomes
- Overall response rate, complete remission rate, safety and tolerability
- Secondary Outcomes
- Progression-free survival, overall survival, duration of response, pharmacokinetics
- Safety Considerations
- Monitoring for adverse events, dose-limiting toxicities, and effect on cardiac repolarization (QTc)
- Patient Populations
- Adults with various blood cancers, solid tumors, and healthy volunteers for some studies
What is Cedazuridine?
Cedazuridine is a new drug being studied for the treatment of various blood cancers and related disorders. It is often referred to by its research name ASTX727 or E7727. Cedazuridine is typically used in combination with another drug called decitabine. Together, they form a medication known as decitabine/cedazuridine, which is also called INQOVI.
How Does Cedazuridine Work?
Cedazuridine works by slowing down how quickly the body breaks down decitabine. This allows decitabine to remain active in the body for a longer time, potentially making it more effective at treating cancer. Decitabine is a type of drug that can block abnormal cells or cancer cells from growing. Together, cedazuridine and decitabine may help control the growth of cancer cells in the body.
What Conditions Does Cedazuridine Treat?
Cedazuridine, in combination with decitabine, is being studied to treat several types of blood cancers and related disorders, including:
- Myelodysplastic Syndromes (MDS): A group of disorders where the bone marrow doesn't produce enough healthy blood cells
- Acute Myeloid Leukemia (AML): A type of blood and bone marrow cancer
- Chronic Myelomonocytic Leukemia (CMML): A type of blood cancer that affects certain white blood cells
- Mesothelioma: A type of cancer that develops in the lining that covers the outer surface of some of the body's organs
How is Cedazuridine Given?
Cedazuridine is typically given as an oral medication (taken by mouth) in the form of tablets or capsules. It is usually taken once daily for several days as part of a treatment cycle. The exact dosing schedule can vary depending on the specific condition being treated and the individual patient's needs.
Cedazuridine in Combination Therapies
Cedazuridine is often used in combination with other cancer drugs to potentially enhance treatment effectiveness. Some combination therapies being studied include:
- Cedazuridine + Decitabine + Venetoclax: This combination is being studied for treating acute myeloid leukemia
- Cedazuridine + Decitabine + Magrolimab: This combination is being researched for myelodysplastic syndromes
- Cedazuridine + Decitabine + Enzalutamide: This combination is being studied for prostate cancer
Potential Side Effects
As with all medications, cedazuridine may cause side effects. The full range of potential side effects is still being studied in clinical trials. Common side effects of cancer treatments may include fatigue, nausea, decreased blood cell counts, and increased risk of infections. It's important to discuss potential side effects with your healthcare provider.
Ongoing Research
Cedazuridine is still being actively studied in clinical trials. Researchers are investigating its effectiveness in treating various types of cancer, optimal dosing schedules, and potential combinations with other drugs. If you're interested in participating in a clinical trial involving cedazuridine, talk to your doctor about whether you might be eligible.